Latham John A

Avg. Two Year Performance

No purchase track record
38% Avg. Sale Return
17% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return5%6%14%28%38%
Sale Success Rate18 of 2416 of 2417 of 2416 of 2418 of 24
Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 244.18K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--